InsiderClue
← All stocks

Grace Therapeutics, Inc.

GRCE Net buying
CIK 0001444192 #4746 in the set updated 17 Sep 2026
Bought (120 mo)
$1.52M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.52M
+$1.52M against sales at will

By person

4 insiders · 6 transactions
0.4×

Prashant Kohli holds only 0.4 times base salary in stock. $259.70K of shares against $579.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Prashant Kohli last reported holding, valued at $2.14, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kavuru Vimal
Director
$1.25M (1)
—
+$1.25M
1,188,076
7.30%
$2.54M
+132.2%
Kohli Prashant
Chief Executive Officer
$214.00K (1)
—
+$214.00K
121,357
0.7457%
$259.70K
+468.2%
Opaleye Management Inc. entity
10% owner
$56.10K (3)
—
+$56.10K
5,535,229
34.01%
$11.85M
+0.5%
Olds Donald
Director
$781.05 (1)
—
+$781.05
381
0.0023%
$815.34
—

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Kohli Prashant
9 Sep 2026
Chief Executive Officer
Buy
100,000
$2.14
$214.00K
Opaleye Management Inc.
9 Sep 2026
10% owner
Buy indirect
5,836
$2.09
$12.20K
Opaleye Management Inc.
8 Sep 2026
10% owner
Buy indirect
9,393
$2.10
$19.70K
Opaleye Management Inc.
14 Aug 2026
10% owner
Buy indirect
11,608
$2.09
$24.21K
Kavuru Vimal
25 Sep 2023
Director
Buy indirect
676,371
$1.85
$1.25M
Olds Donald
31 Aug 2023
Director
Buy
381
$2.05
$781.05

What was left out

Form 4 filings counted 55
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Nov 2021